54 |
Explore the Rationale for the Dual Mechanism CCB/ARB Approaches in Hypertension Management |
Jeong Bae Park |
Oct. 24. 08 |
53 |
Improving Outcomes in CV & Metabolic Disease, Landmark Trials Across the Continuum |
Dong-Ju Choi |
Oct. 24. 08 |
52 |
Triple Antiplatelet Therapy After DES Implantation in Patients with High Risk of Restenosis |
Seong-Wook Park |
Oct. 24. 08 |
51 |
Is Triple Anti-Platelet Therapy a Solution for Patients with Aspirin/Plavix Resistance ? |
Jung-Won Suh |
Oct. 24. 08 |
50 |
How Long Patients Will Be on Dual Antiplatelet Therapy? |
Ron Waksman |
Oct. 24. 08 |
49 |
Insights into Antiplatelet Therapy: From CAPRIE to TRITON-TIMI 38 |
Cheol Whan Lee |
Oct. 24. 08 |
48 |
Plaque Stabilization and Regression After Statin Therapy Evaluated With Both Intravascular Ultrasound and Coronary Angioscope |
Junko Honye |
Oct. 10. 08 |
47 |
Triple Antiplatelet Therapy Significantly Reduced Stent Thrombosis After Drug-Eluting Stent Implantation |
Seong-Wook Park |
Jul. 18. 08 |
46 |
Optimizing Antiplatelet Therapy in PCI/ Antiplatelet Therapy After PCI: How Much and How Long? |
Adnan Kastrati |
Jul. 18. 08 |
45 |
DES Thrombosis How Long Patients Will Be on Dual Antiplatelet Therapy? |
Ron Waksman |
Jul. 18. 08 |